AGP Executive Report
Last update: 11 hours agoMedical Cannabis Policy: England’s patient safety watchdog says nearly 2 million unlicensed cannabis items were issued on private prescriptions in a year, raising alarms about online access and patient risk. Regulation & Compliance: In Australia, Avecho says its CBD sleep capsule trial is moving forward after a positive interim readout, while Elixinol inks a deal to buy Vitable to boost recurring wellness revenue. Hemp & Agriculture: Scotland’s hemp pilot is being pitched as a “new olive oil” crop after farmers tout seed-oil and environmental benefits. Enforcement & Courts: Ireland reports a €350k cannabis seizure in Cork with two men charged; Florida and UK local reports also flag cannabis-related arrests and public-use concerns. Public Health & Youth: Trinidad and Tobago lawmakers debate raising the cannabis age limit to 25, with critics warning it could push more trade underground. International Politics: Cambodia’s PM reiterates opposition to cannabis cultivation and also rejects vape investment, citing control and youth health risks. Industry Watch: US hemp THC firms brace for looming federal restrictions as the market faces uncertainty.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.